Diagnostic assays for Crimean-Congo hemorrhagic fever

Emerging Infectious Diseases

Volumn 18, Issue 12, 2012, Pages 1958-1965

  Vanhomwegen, Jessica ^a,b   Alves, Maria João ^c   Županc, Tatjana Avšič ^d   Bino, Silvia ^e   Chinikar, Sadegh ^f   Karlberg, Helen ^g   Korukluoǧlu, Gülay ^h   Korva, Miša ^d   Mardani, Masoud ⁱ   Mirazimi, Ali ^g   Mousavi, Mehrdad ^g   Papa, Anna ^j   Saksida, Ana ^d   Sharifi Mood, Batool ⁱ   Sidira, Persofoni ^j   Tsergouli, Katerina ^j   Wölfel, Roman ^k   Zeller, Hervé ^b   Dubois, Philippe ^a  

^a INSTITUT PASTEUR   (France)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

^e Institute of Public Health   (Albania)

^f PASTEUR INSTITUTE OF IRAN   (Iran)

^g SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^h Refik Saydam National Public Health Agency   (Turkey)

ⁱ SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^k BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84869763809     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1812.120710     Document Type: Article

References (34)

1. Morikawa S, Saijo M, Kurane I. Recent progress in molecular biology of Crimean-Congo hemorrhagic fever. Comp Immunol Microbiol Infect Dis. 2007;30:375-89. http://dx.doi.org/10.1016/j. cimid.2007.07.001
2. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:145-60. http://dx.doi.org/10.1016/j.antiviral.2004.08.001
3. Episouth. Epidemiology of Crimean-Congo haemorrhagic fever virus: Albania, Bulgaria, Greece, Islamic Republic of Iran, Kosovo, Russian Federation, Turkey. 2008 Oct 1 [cited 2011 Nov 15]. http://www.episouth.org/outputs/wp6/Episouth_CCHF_01_10_2008_final.pdf
4. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979;15:307-417.
5. Ergonul O, Whitehouse CH, editors. Crimean-Congo hemorrhagic fever: a global perspective. Dordrecht (the Netherlands): Springer; 2007.
6. Appannanavar SB, Mishra B. An update on Crimean Congo hemorrhagic fever. J Glob Infect Dis. 2011;3:285-92. http://dx.doi. org/10.4103/0974-777X.83537
7. Leblebicioglu H. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents. 2010;36(Suppl 1):S43-6. http://dx.doi. org/10.1016/j.ijantimicag.2010.06.020
8. Chinikar S, Ghiasi SM, Hewson R, Moradi M, Haeri A. Crimean-Congo hemorrhagic fever in Iran and neighboring countries. J Clin Virol. 2010;47:110-4. http://dx.doi.org/10.1016/j.jcv.2009.10.014
9. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-14. http://dx.doi.org/10.1016/S1473-3099(06)70435-2
10. Maltezou HC, Papa A. Crimean-Congo hemorrhagic fever: Risk for emergence of new endemic foci in Europe? Travel Med Infect Dis. 2010;8:139-43. http://dx.doi.org/10.1016/j.tmaid.2010.04.008
11. Maltezou HC, Andonova L, Andraghetti R, Bouloy M, Ergonul O, Jongejan F, et al. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill. 2010;15:19504.
12. European Center for Disease Control and Prevention. Consultation on Crimean-Congo haemorrhagic fever prevention and control. Meeting report. 2008 Sep [cited 2011 Nov 15]. http://ecdc.europa. eu/en/publications/Publications/0809_MER_Crimean_Congo_Haemorragic_Fever_Prevention_and_Control.pdf
13. World Health Organization. Fièvre hémorragique Crimée-Congo, hantavirus et fièvre hémorragique Alkhurma-menaces de maladies infectieuses émergentes. Rapport du Secrétariat. 2010 Apr 15 [cited 2011 Nov 16]. http://apps.who.int/gb/ebwha/pdf_files/EB127/B127_3-fr.pdf
14. Ke R, Zorzet A, Göransson J, Lindegren G, Sharifi-Mood B, Chinikar S, et al. A colorimetric nucleic acid testing assay for RNA virus detection based on circle-to-circle amplification of padlock probes. J Clin Microbiol. 2011;49:4279-85. http://dx.doi. org/10.1128/JCM.00713-11
15. Drosten C, Kümmerer BM, Schmitz H, Günther S. Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res. 2003;57:61-87. http://dx.doi.org/10.1016/S0166-3542(02)00201-2
16. Burt FJ, Leman P, Smith J, Swanepoel R. The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J Virol Methods. 1998;70:129-37. http://dx.doi.org/10.1016/S0166-0934(97)00182-1
17. Duh D, Saksida A, Petrovec M, Ahmeti S, Dedushaj I, Panning M, et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis. 2007;13:1769-72. http://dx.doi. org/10.3201/eid1311.070222
18. Wölfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, Hewson R, et al. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis. 2007;13:1097-100. http://dx.doi.org/10.3201/eid1307.070068
19. Saijo M, Qing T, Niikura M, Maeda A, Ikegami T, Sakai K, et al. Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol. 2002;40:372-5. http://dx.doi.org/10.1128/JCM.40.2.372-375.2002
20. Saijo M, Qing T, Niikura M, Maeda A, Ikegami T, Prehaud C, et al. Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol. 2002;40:1587-91. http://dx.doi.org/10.1128/JCM.40.5.1587-1591.2002
21. Emmerich P, Avsic-Zupanc T, Chinikar S, Saksida A, Thomé-Bolduan C, Parczany-Hartmann A, et al. Early serodiagnosis of acute human Crimean-Congo hemorrhagic fever virus infections by novel capture assays. J Clin Virol. 2010;48:294-5. http://dx.doi. org/10.1016/j.jcv.2010.05.002
22. Samudzi RR, Leman PA, Paweska JT, Swanepoel R, Burt FJ. Bacterial expression of Crimean-Congo hemorrhagic fever virus nucleoprotein and its evaluation as a diagnostic reagent in an indirect ELISA. J Virol Methods. 2012;179:70-6. http://dx.doi. org/10.1016/j.jviromet.2011.09.023
23. Schwarz TF, Nsanze H, Longson M, Nitschko H, Gilch S, Shurie H, et al. Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am J Trop Med Hyg. 1996;55:190-6.
24. Papa A, Drosten C, Bino S, Papadimitriou E, Panning M, Velo E, et al. Viral load and Crimean-Congo hemorrhagic fever. Emerg Infect Dis. 2007;13:805-6. http://dx.doi.org/10.3201/eid1305.061588
25. Rodriguez LL, Maupin GO, Ksiazek TG, Rollin PE, Khan AS, Schwarz TF, et al. Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg. 1997;57:512-8.
26. Wölfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, Hewson R, et al. Low-density macroarray for rapid detection and identification of Crimean-Congo hemorrhagic fever virus. J Clin Microbiol. 2009;47:1025-30. http://dx.doi.org/10.1128/JCM.01920-08
27. Papa A. Crimean-Congo hemorrhagic fever virus, northeastern Greece. Emerg Infect Dis. 2011;17:141-3. http://dx.doi.org/10.3201/eid1701.100073
28. Humolli I, Dedushaj I, Zupanac TA, Muçaj S. Epidemiological, serological and herd immunity of Crimean-Congo haemorrhagic fever in Kosovo. Med Arh. 2010;64:91-3.
29. Suleiman MN, Muscat-Baron JM, Harries JR, Satti AG, Platt GS, Bowen ET, et al. Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital. Lancet. 1980;2:939-41.
30. Zakhashvili K. Crimean-Congo hemorrhagic fever in man, Republic of Georgia, 2009. Emerg Infect Dis. 2010;16:1326-8. http://dx.doi. org/10.3201/eid1608.100181
31. Randolph SE, Rogers DJ. The arrival, establishment and spread of exotic diseases: patterns and predictions. Nat Rev Microbiol. 2010;8:361-71. http://dx.doi.org/10.1038/nrmicro2336
32. World Health Organization. International Health Regulations (2005), 2nd ed. 2008 [cited 2012 Feb 15]. http://whqlibdoc.who.int/publications/2008/9789241580410_eng.pdf
33. European Center for Disease Control and Prevention. Strategies for disease-specific programmes 2010-2013. 2010 Jul [cited 2012 Feb 15]. http://ecdc.europa.eu/en/publications/Publications/100714_COR_Strategies_for_disease-specific_programmes_2010-2013.pdf
34. Escadafal C, Öhlschläger S, Avšič-Županc T, Vanhomwegen J, Mirazimi A, Teichmann A, et al. First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis. 2012;6:e1706. Epub 2012 Jun 26. http://dx.doi.org/10.1371/journal.pntd.0001706